Cargando…

Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery

This study concerns the supercritical antisolvent process which allows single-step production of 5-fluorouracil (5-FU) nanoparticles. This process enhances the physical characteristics of 5-FU in order to deliver it directly to the respiratory tract. Several mixtures of methanol with dichloromethane...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalantarian, Pardis, Najafabadi, Abdolhosein Rouholamini, Haririan, Ismaeil, Vatanara, Alireza, Yamini, Yadollah, Darabi, Majid, Gilani, Kambiz
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962272/
https://www.ncbi.nlm.nih.gov/pubmed/21042422
http://dx.doi.org/10.2147/IJN.S12415
_version_ 1782189180273557504
author Kalantarian, Pardis
Najafabadi, Abdolhosein Rouholamini
Haririan, Ismaeil
Vatanara, Alireza
Yamini, Yadollah
Darabi, Majid
Gilani, Kambiz
author_facet Kalantarian, Pardis
Najafabadi, Abdolhosein Rouholamini
Haririan, Ismaeil
Vatanara, Alireza
Yamini, Yadollah
Darabi, Majid
Gilani, Kambiz
author_sort Kalantarian, Pardis
collection PubMed
description This study concerns the supercritical antisolvent process which allows single-step production of 5-fluorouracil (5-FU) nanoparticles. This process enhances the physical characteristics of 5-FU in order to deliver it directly to the respiratory tract. Several mixtures of methanol with dichloromethane, acetone, or ethanol were used for particle preparation, and their effects on the physical characteristics of the final products were studied. The conditions of the experiment included pressures of 100 and 150 bar, temperature of 40°C, and a flow rate of 1 mL/min. The particles were characterized physicochemically before and after the process for their morphology and crystallinity. In spite of differences in size, the particles were not very different regarding their morphology. The resulting particles were of a regular shape, partly spherical, and appeared to have a smooth surface, whereas the mechanically milled particles showed less uniformity, had surface irregularities and a high particle size distribution, and seemed aggregated. Particles of 5-FU precipitated from methanol-dichloromethane 50:50 had a mean particle size of 248 nm. In order to evaluate the aerodynamic behavior of the nanoparticles, six 5-FU dry powder formulations containing mixtures of coarse and fine lactose of different percentages were prepared. Deposition of 5-FU was measured using a twin-stage liquid impinger and analyzed using a validated high pressure liquid chromatography method. Addition of fine lactose improved the aerodynamic performance of the drug, as determined by the fine particle fraction.
format Text
id pubmed-2962272
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-29622722010-11-01 Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery Kalantarian, Pardis Najafabadi, Abdolhosein Rouholamini Haririan, Ismaeil Vatanara, Alireza Yamini, Yadollah Darabi, Majid Gilani, Kambiz Int J Nanomedicine Original Research This study concerns the supercritical antisolvent process which allows single-step production of 5-fluorouracil (5-FU) nanoparticles. This process enhances the physical characteristics of 5-FU in order to deliver it directly to the respiratory tract. Several mixtures of methanol with dichloromethane, acetone, or ethanol were used for particle preparation, and their effects on the physical characteristics of the final products were studied. The conditions of the experiment included pressures of 100 and 150 bar, temperature of 40°C, and a flow rate of 1 mL/min. The particles were characterized physicochemically before and after the process for their morphology and crystallinity. In spite of differences in size, the particles were not very different regarding their morphology. The resulting particles were of a regular shape, partly spherical, and appeared to have a smooth surface, whereas the mechanically milled particles showed less uniformity, had surface irregularities and a high particle size distribution, and seemed aggregated. Particles of 5-FU precipitated from methanol-dichloromethane 50:50 had a mean particle size of 248 nm. In order to evaluate the aerodynamic behavior of the nanoparticles, six 5-FU dry powder formulations containing mixtures of coarse and fine lactose of different percentages were prepared. Deposition of 5-FU was measured using a twin-stage liquid impinger and analyzed using a validated high pressure liquid chromatography method. Addition of fine lactose improved the aerodynamic performance of the drug, as determined by the fine particle fraction. Dove Medical Press 2010-10-05 2010 /pmc/articles/PMC2962272/ /pubmed/21042422 http://dx.doi.org/10.2147/IJN.S12415 Text en © 2010 Kalantarian et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Kalantarian, Pardis
Najafabadi, Abdolhosein Rouholamini
Haririan, Ismaeil
Vatanara, Alireza
Yamini, Yadollah
Darabi, Majid
Gilani, Kambiz
Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
title Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
title_full Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
title_fullStr Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
title_full_unstemmed Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
title_short Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
title_sort preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962272/
https://www.ncbi.nlm.nih.gov/pubmed/21042422
http://dx.doi.org/10.2147/IJN.S12415
work_keys_str_mv AT kalantarianpardis preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery
AT najafabadiabdolhoseinrouholamini preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery
AT haririanismaeil preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery
AT vatanaraalireza preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery
AT yaminiyadollah preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery
AT darabimajid preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery
AT gilanikambiz preparationof5fluorouracilnanoparticlesbysupercriticalantisolventsforpulmonarydelivery